Basf Venture Capital And Orbia Ventures Invest In Israeli Biotech Company Fortephest
Feb 10, 2022•over 3 years ago
Description
BASF Venture Capital GmbH (BVC) and Orbia Ventures today announce their Series-B investment in the Israeli biotech startup FortePhest. Founded in 2017, FortePhest is developing a new technology to combat herbicide-resistant weeds and invasive plants. Inspired and informed by natural plant processes, the company supports crop protection on a global scale by implementing this technology. BASF Venture Capital and Orbia Ventures are joined by Sherpa InnoVentures, SIBF II and other investors for this funding round